{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-377493","form_type":"8-K","ticker":"IVVD","cik":"0001832038","company_name":"Invivyd, Inc.","filed_at":"2026-09-01T11:10:26+00:00","discovered_at":"2026-09-01T11:15:01.291463+00:00","generated_at":"2026-09-01T11:15:06.704216+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Invivyd names Chairman Marc Elia CEO; VYD2311 data expected end of Q3 2026","bullets":["Marc Elia, former Chairman, appointed CEO effective Aug 30, 2026; retains Chairman role.","Elia gets $750k base salary, $500k sign-on bonus, option for 10.7M shares vesting over 4 years.","Ajay Royan named Lead Independent Director; Ian Sheffield joins board as independent director.","VYD2311 top-line data from DECLARATION/LIBERTY expected around end of Q3 2026; BLA submission planned via traditional or accelerated approval.","Company in FDA discussions; either route could provide near-term pathway to make VYD2311 available."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-377493","json":"https://secwatch.observer/filing/0001193125-26-377493.json","markdown":"https://secwatch.observer/filing/0001193125-26-377493.md","text":"https://secwatch.observer/filing/0001193125-26-377493.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832038/000119312526377493/0001193125-26-377493-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832038/000119312526377493/ivvd-20260830.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-01T11:15:06.704216+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2464d2b096","claim":"Marc Elia was appointed as Chief Executive Officer at Invivyd, Inc..","evidence_excerpt":"On August 30, 2026, the Board of Directors (the “Board”) of Invivyd, Inc. (the “Company”) appointed Marc Elia, Chairman of the Board, as the Company’s Chief Executive Officer, effective as of August 30, 2026","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832038/000119312526377493/0001193125-26-377493-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"614c49b1fe","claim":"William Duke, Jr. changed role as Chief Financial Officer at Invivyd, Inc..","evidence_excerpt":"Mr. Elia will serve as the Company’s principal executive officer, a role previously held by William Duke, Jr., the Company’s Chief Financial Officer, who remains the Company’s principal financial officer and principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832038/000119312526377493/0001193125-26-377493-index.htm","confidence":0.7,"family_label":"Executive change","details":[{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"7ff42cfc20","claim":"Ajay Royan was appointed as Lead Independent Director at Invivyd, Inc..","evidence_excerpt":"the Board appointed Ajay Royan as the Lead Independent Director of the Board, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832038/000119312526377493/0001193125-26-377493-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Lead Independent Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}